Prospective, randomized, single masked pilot study on the variation of choroidal blood flow analyzed through the HRA dynamic angiography in patients treated with intravitreal injection of Selective anti-VEGF (Macugen) or Pan anti-VEGF (Avastin).
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2014
At a glance
- Drugs Bevacizumab (Primary) ; Pegaptanib
- Indications Choroidal neovascularisation; Wet age-related macular degeneration
- Focus Therapeutic Use
- 09 Mar 2014 New trial record